Skip to main content
SpringerLink
Log in

Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs

  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Somatostatin receptor (SSTR) subtypes 1, 2, and 5 are expressed in the normal human pituitary. SSTR2 and SSTR5 are expressed in almost all growth hormone (GH) cell adenomas, and prolactin (PRL)-secreting tumors express SSTR5 more than SSTR2. SSTR4 is not detected in all pituitary adenoma subtypes, and SSTR1 and SSTR3 are expressed in about 50% of tumors. Human GH is regulated through ligand binding to both SSTR2 and SSTR5, but octreotide and lanreotide, the two clinically available somatostatin analogs, bind to human SSTR2 much better than to SSTR5. Novel SSTR2- and SSTR5-selective analogs with improved binding affinity for these receptor subtypes are highly potent in suppressing GH release from cultures of human fetal pituitaries or GH-cell adenomas. Only SSTR5-selective analogs suppress in vitro PRL secretion from cultured prolactinomas. A new SSTR2+5 bispecific analog with high affinity and selectivity for both SSTR2 and SSTR5, and a somatostatin analog with a unique broad receptor (SSTR1, 2, 3, and 5) binding profile, are both able to inhibit in vitro GH release in GH cell adenomas partially sensitive to octreotide. Recently, a somatostatindopamine hybrid molecule was introduced with potentially functional synergy on GH and PRL release. Using the expanding knowledge on SSTRs and their ligand activation, the development of novel pharmacologic concepts may open new opportunities for effective manipulation of this complex intracellular signaling system. These concepts may achieve better control of pituitary hormone hypersecretion, pituitary size, as well as antitumor effects in patients with SSTR-expressing tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brazeau, P., Vale, W., Burgus, R., Ling, M., Rivier, J., and Guillemin, R. (1972). Science 129, 77–79.

    Google Scholar 

  2. Lamberts, S. W. J. (1988). Endocr. Rev. 9, 417–436.

    Article  PubMed  CAS  Google Scholar 

  3. Mandarino, L., Stenner, D., Blanchard, W., et al. (1981). Nature 291, 76, 77.

    Article  PubMed  CAS  Google Scholar 

  4. Reisine, T. and Bell, G. I. (1995). Endocr. Rev. 16, 427–442.

    Article  PubMed  CAS  Google Scholar 

  5. Patel, Y. C. and Srikant, C. B. (1997). Trends Endocrinol. Metab. 8, 398–405.

    Article  CAS  PubMed  Google Scholar 

  6. Breder, C. D., Yamada, Y., Yasuda, K., Seino, S., Saper, C. B., and Bell. G. I. (1992). J. Neurosci. 12, 3920–3934.

    PubMed  CAS  Google Scholar 

  7. Kaupmann, K., Bruns, C., Hoyer, D., Seuwen, K., and Lubbert, H. (1993). FEBS Lett. 331, 53–59.

    Article  PubMed  CAS  Google Scholar 

  8. Day, R., Dong, W., Panetta, R., Kraicer, J., Greenwood, M. T., and Patel, Y. C. (1995). Endocrinology 136, 5232–5235.

    Article  PubMed  CAS  Google Scholar 

  9. Shimon, I., Taylor, J. E., Dong, J. Z., et al. (1997). J. Clin. Invest. 99, 789–798.

    Article  PubMed  CAS  Google Scholar 

  10. Miller, G. M., Alexander, J. M., Bikkal, H. A., Katznelson, L., Zervas, N. T., and Klibanski, A. (1995). J. Clin. Endocrinol. Metab. 80, 1286–1392.

    Google Scholar 

  11. Panetta, R. and Patel, Y. C. (1995). Life Sci. 56, 333–342.

    Article  PubMed  CAS  Google Scholar 

  12. Greenman, Y. and Melmed, S. (1994). J. Clin. Endocrinol. Metab. 78, 398–403.

    Article  PubMed  CAS  Google Scholar 

  13. Greenman, Y. and Melmed, S. (1994). J. Clin. Endocrinol. Metab. 79, 724–729.

    Article  PubMed  CAS  Google Scholar 

  14. Jaquet, P., Ouafik, L., Saveanu, A., et al. (1999). J. Clin. Endocrinol. Metab. 84, 3268–3276.

    Article  PubMed  CAS  Google Scholar 

  15. Jaquet, P., Saveanu, A., Gunz, G., et al. (2000). J. Clin. Endocrinol. Metab. 85, 781–792.

    Article  PubMed  CAS  Google Scholar 

  16. Newman, C. B., Melmed, S., Snyder, P. J., et al. (1995). J. Clin. Endocrinol. Metab. 80, 2768–2775.

    Article  PubMed  CAS  Google Scholar 

  17. Caron, P., Morange-Ramos, I., Conge, M., and Jaquet, P. (1997). J. Clin. Endocrinol. Metab. 82, 18–22.

    Article  PubMed  CAS  Google Scholar 

  18. O’Carroll, A. M., Raynor, K., Lolait, S. J., and Reisine, T. (1994). Mol. Pharmacol. 48, 291–298.

    Google Scholar 

  19. Moreau, J.-P., Kim, S., Dong, J. Z., et al. (1996). Metabolism 45(Suppl. 1), 24–28.

    Article  PubMed  CAS  Google Scholar 

  20. Coy, D. H. and Taylor, J. E. (1996). Metabolism 45(Suppl. 1), 21–23.

    Article  PubMed  CAS  Google Scholar 

  21. Shimon, I., Yan, X., Taylor, J. E., Weiss, M. H., Culler, M. D., and Melmed, S. (1997). J. Clin. Invest. 100, 2386–2392.

    PubMed  CAS  Google Scholar 

  22. Yang, L., Berk, S. C., Rohrer, S. P., et al. (1998). Proc. Natl. Acad. Sci. USA 95, 10,836–10,841.

    CAS  Google Scholar 

  23. Rohrer, S. P., Birzin, E. T., Mosley, R. T., et al. (1998). Science 282, 737–740.

    Article  PubMed  CAS  Google Scholar 

  24. Sharma, K., Patel, Y. C., and Srikant, C. B. (1996). Mol. Endocrinol. 10, 1688–1696.

    Article  PubMed  CAS  Google Scholar 

  25. Lamberts, S. W. J., van der Lely, A. J., and Hofland, L. J. (2002). Eur. J. Endocrinol. 146, 701–705.

    Article  PubMed  CAS  Google Scholar 

  26. Saveanu, A., Gunz, G., Dufour, H., et al. (2001). J. Clin. Endocrinol. Metab. 86, 140–145.

    Article  PubMed  CAS  Google Scholar 

  27. Zambre, Y., Ling, Z., Chen, M. C., et al. (1999). Biochem. Pharmacol. 57, 1159–1164.

    Article  PubMed  CAS  Google Scholar 

  28. Tulipano, G., Soldi, D., Bagnasco, M., et al. (2002). Endocrinology 143, 1218–1224.

    Article  PubMed  CAS  Google Scholar 

  29. Bruns, C., Lewis, I., Briner, U., Meno-Tetang, G., and Weckbecker, G. (2002). Eur. J. Endocrinol. 146, 707–716.

    Article  PubMed  CAS  Google Scholar 

  30. Murray, R. D., Kim, K., Ren, S. G., Weckbecher, G., Bruns, C., and Melmed, S. (2002). In: Abstracts of the Endocrine Society’s 84th Annual Meeting, San Francisco (abstract OR58-6).

  31. Hofland, L. J., Bruns, C., Weckbecker, G., et al. (2002). In: Abstracts of the Endocrine Society’s 84th Annual Meeting, San Francisco (abstract P2–108).

  32. Afargan, M., Janson, E. T., Gelerman, G., et al. (2001). Endocrinology 142, 477–486.

    Article  PubMed  CAS  Google Scholar 

  33. Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., and Patel, Y. C. (2000). J. Biol. Chem. 275, 7862–7869.

    Article  PubMed  CAS  Google Scholar 

  34. Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., and Patel, Y. C. (2000). Science 288, 154–157.

    Article  PubMed  CAS  Google Scholar 

  35. Saveanu, A., Lavaque, E. D., Gunz, G., et al. (2002). J. Clin. Endocrinol. Metab. 87, 5545–5552.

    Article  PubMed  CAS  Google Scholar 

  36. Gulec, S. A., Drouant, G. J., Fuselier, J., et al. (2001). J. Surg. Res. 97, 131–137.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Endocrinology, Chaim Sheba Medical Center, 52621, Tel-Hashomer, Israel

    Ilan Shimon

Authors
  1. Ilan Shimon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ilan Shimon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimon, I. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs. Endocr 20, 265–269 (2003). https://doi.org/10.1385/ENDO:20:3:265

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:20:3:265

Key Words

Search

Navigation